The hypothesis that environmental factors may 'imprint' on the fetus and contribute to adult health has been stimulated by the work of Barker and colleagues (1) . Metabolic imprinting has two key features; (a) there is a critical window during fetal development or early life when the fetus is particularly sensitive to exposures; and (b) the exposure leads to changes that persist throughout adulthood. Waterland and Garza (2) have recently proposed several mechanisms for metabolic imprinting. Apart from induced variations in organ structure (e.g. vascularization and/or innervation during organogenesis) and alterations in cell numbers (e.g. changes in neuronal count/density after prenatal malnutrition), metabolic imprinting may be mediated by clonal selection and metabolic differentiation. Clonal selection may have long-lasting effects if early nutritional or hormonal exposures differentially advantage certain cell lines: the more numerous facilitated daughter cells may have persisting consequences for the adult organism. Imprinting may also operate by 'metabolic differentiation': the process of cells acquiring a stable quantitative pattern of basal and inducible gene expression. These mechanisms may relate to enzymes, hormones and their receptors and other components of cellular molecular biology. Metabolic differentiation includes epigenetic mechanisms related to chromatin structure, DNA methylation, and autoregulatory patterns of DNA binding protein.
HEALTH AND VITAMIN D: CLUES FROM BIOLOGY AND EPIDEMIOLOGY
Evidence linking vitamin D and various disorders is based on in vitro, animal and ecological-level research. None of these features in isolation would be sufficient 'proof' that vitamin D is involved in causal pathways; however, the coherence of the data suggests that low vitamin D is a Does 'imprinting' with low prenatal vitamin D contribute to the risk of various adult disorders?
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(1) In vitro and animal experiments. Vitamin D can ameliorate the expression of animal models of multiple sclerosis (7) and diabetes mellitus (8) . Vitamin D can lead to increased differentiation in cell cultures derived from prostate (9), breast (10) and colorectal cancer (11) . (2) Incidence/prevalence associations with latitude.
Many diseases have gradients in incidence, prevalence and outcome that are correlated with latitude. Latitude acts as a risk indicator (or proxy) for the population distribution of serum vitamin D levels. A negative correlation between latitude and disease incidence is found for disorders such as multiple sclerosis (12, 13) , breast cancer (14), prostate cancer (15), colorectal cancer (6), insulin dependent diabetes mellitus (16)(17) and schizophrenia (18, 19) . (3) Ultraviolet B radiation (UVB). The geographical distribution of several diseases has been linked to measures related to the availability of UVB. This exposure is strongly correlated with latitude and vitamin D levels (20) . Diseases that have been associated with measures related to sunshine include multiple sclerosis (12) , breast cancer (21, 22) , prostrate cancer (15, 23) , colorectal cancer (14, 23, 24) , and insulin dependent diabetes mellitus (25) . The between-year fluctuations in schizophrenia birth rates have also been linked to measures of sunshine (26) . (4) Season of birth. The amount of ultraviolet radiation fluctuates across the seasons such that individuals born in winter and early spring tend to be exposed to lower levels of vitamin D than those born in other months. Disorders that have an excess of winter/spring births suggest that early life exposures to low vitamin D may be a riskmodifying exposure. There is robust evidence from the Northern Hemisphere showing that schizophrenia has seasonality of birth (27) , and similar but weaker evidence for multiple sclerosis (28) . (5) Urban-rural gradient. Urban residence is associated with higher prevalence of hypovitaminosis D (20) .
Diseases that have urban excess include breast cancer (29) and schizophrenia (30) . Urban residence is also strongly linked to air pollution, a local factor that influences the availability of UVB. Colorectal and breast cancer (31) 
HYPOTHESIS
While the incidence of rickets has declined markedly over the last century, hypovitaminosis D is still relatively common in developed and developing countries (36, 37) . A large US survey reported that 12% of women aged 20 to 39 (peak ages for child-bearing) had serum 25-hydroxyvitamin D 3 levels below the threshold defined for vitamin D deficiency (≤ 15 ng/ml) (38) . Pregnant women are at risk of hypovitaminosis D because of the increased needs of the fetus and the potential for these women to reduce their outdoor activity, leading to diminished supply of vitamin D (39, 40) . I propose that low pre-and perinatal vitamin D 'imprints' on a range of tissues, leaving the affected individual at increased risk of developing a range of disorders including osteoporosis, multiple sclerosis, breast cancer, prostate cancer, colorectal cancer, insulin-dependent diabetes mellitus and schizophrenia. The early life exposure contributes to risk status in addition to other factors such as genetic susceptibility and adult exposures (including hypovitaminosis during adult life). With respect to the putative mechanisms of metabolic imprinting, it is proposed that vitamin D mediated alterations in neuronal proliferation, differentiation, migration and apoptosis may be implicated in schizophrenia. Vitamin (42) . Factors related to clonal selection and metabolic differentiation may be particularly important in the vitamin D related cancers (breast, prostate, colorectal), multiple sclerosis and insulin-dependent diabetes mellitus. This hypothesis gains biological plausibility from the demonstration of persisting alterations in cellular responsivity and organ differentiation after early-life exposure to vitamin D (43, 44) .
Interestingly, low prenatal vitamin D has recently been implicated in the pathogenesis of syndrome 'X' (increased insulin resistance, hyperlipidaemia, hypertension, central obesity, increased fibrinogen and increased risk of noninsulin dependent diabetes mellitus) (45) . It is proposed that low prenatal vitamin D might contribute to low birth weight and program aspects of pancreatic islet beta cell function. These features would then amplify the consequences of adult hypovitaminosis, thus leading to increased risk of syndrome 'X' . A diverse range of evidence suggests that low prenatal vitamin D is a candidate exposure for a range of adverse adult health outcomes.
TESTING THE HYPOTHESIS
One could measure vitamin D levels in a large cohort of pregnant women, and then follow-up their offspring for several decades in order to search for a dose-response relationship (a biological gradient) between low Vitamin D and increased risk of the candidate disorders. If sera from pregnant women and/or cord blood from their offspring were 'banked down' during past decades, maternal vitamin D levels and rates of candidate disorders in the offspring could be examined.
From an ecological perspective, 'natural' and opportunistic experiments that impact on Vitamin D may provide exposed and non-exposed cohorts for birthrate comparisons (e.g. famine, clusters of rickets, the introduction of vitamin D supplementation). Between-year fluctuations in birth rates of candidate disorders could be examined for associations with duration of sunshine. For example, geographically-defined birth cohorts (born over several decades) could be divided according to quartiles of perinatal sunshine exposure, and rates of diseases could be compared between these quartiles. It would be predicted, for example, that rates of schizophrenia, diabetes mellitus, multiple sclerosis, breast cancer, prostate cancer and colorectal cancer would be higher in those born during those periods with less sunshine. The hypothesis predicts that vitamin D related disorders will cosegregate in birth cohorts that have been exposed to low prenatal vitamin D. If possible, case-control studies of candidate disorders should ask mothers about prenatal sunshine behaviour, and vitamin D intake. If the hypothesis gains support then a randomized controlled trial of vitamin D supplementation during pregnancy would be indicated; however, the assessment of outcomes would require several decades of observations. Animal experiments could examine the impact on low prenatal vitamin D on a range of health outcomes; however, not all human diseases have robust animal models. The hypothesis also suggests new directions for genetic research: as the hypothesis implicates a prenatal vitamin D deficiency, maternal genes related to vitamin D metabolism warrant consideration in addition to those of the affected offspring.
IMPLICATIONS FOR PUBLIC HEALTH
Programs that aim to reduce the prevalence of hypovitaminosis D in pregnant women could translate into a lower incidence of candidate disorders in their offspring. Just as folate supplementation has been shown to reduce the incidence of neural tube defects (46) , attention to vitamin D status (diet, sunlight exposure) could reduce the burden of a range of diseases. The population attributable fraction of a particular disease that could be linked to low prenatal vitamin D is not clear. In addition, the specificity of the outcomes is weak. However, this feature is a distinct advantage from the public health perspective. If an intervention designed to reduce one particular exposure translates into reduced incidence of several common disorders, then these exposures are deemed more attractive candidates for preventive medicine (47) .
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